Comment On: Testosterone Deficiency in Men with End Stage Renal Disease and Kidney Transplantation: a Narrative Review
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Tillou X, Doerfler A
. Urological tumors in renal transplantation. Minerva Urol Nefrol. 2014; 66(1):57-67.
View
2.
Sherer B, Warrior K, Godlewski K, Hertl M, Olaitan O, Nehra A
. Prostate cancer in renal transplant recipients. Int Braz J Urol. 2017; 43(6):1021-1032.
PMC: 5734064.
DOI: 10.1590/S1677-5538.IBJU.2016.0510.
View
3.
Kleinclauss F, Gigante M, Neuzillet Y, Mouzin M, Terrier N, Salomon L
. Prostate cancer in renal transplant recipients. Nephrol Dial Transplant. 2008; 23(7):2374-80.
DOI: 10.1093/ndt/gfn008.
View
4.
Kauffman H, Cherikh W, Cheng Y, Hanto D, Kahan B
. Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies. Transplantation. 2005; 80(7):883-9.
DOI: 10.1097/01.tp.0000184006.43152.8d.
View
5.
Kamali K, Zargar M
. Effects of renal transplantation on serum-free and total PSA levels. Transplant Proc. 2007; 39(4):1027-8.
DOI: 10.1016/j.transproceed.2007.03.089.
View